102 related articles for article (PubMed ID: 15049675)
1. Lithiation of functionalized fluoroquinolines: synthesis of dihalo-2-phenylquinoline-4-carboxamides and in vitro evaluation as NK-3 receptor ligands for medical imaging studies.
Bennacef I; Tymciu S; Dhilly M; Mongin F; Quéguiner G; Lasne MC; Barré L; Perrio C
J Org Chem; 2004 Apr; 69(7):2622-5. PubMed ID: 15049675
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of novel fluoro and iodo quinoline carboxamides as potential ligands of NK-3 receptors for in vivo imaging studies.
Bennacef I; Tymciu S; Dhilly M; Lasne MC; Debruyne D; Perrio C; Barré L
Bioorg Med Chem; 2004 Aug; 12(16):4533-41. PubMed ID: 15265501
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of halogenated naphthyridone carboxamides as potential ligands for in vivo imaging studies of substance P receptors.
Bagot-Guéret C; Le Bas MD; Tymciu S; Darabantu M; Emond P; Guilloteau D; Lasne MC; Wijkhuisen A; Barré L; Perrio C
Bioconjug Chem; 2003; 14(3):629-41. PubMed ID: 12757389
[TBL] [Abstract][Full Text] [Related]
4. Functionalization through lithiation of (S)-N-(1-phenylpropyl)-2-phenylquinoline-4-carboxamide. Application to the labeling with carbon-11 of NK-3 receptor antagonist SB 222200.
Bennacef I; Perrio C; Lasne MC; Barré L
J Org Chem; 2007 Mar; 72(6):2161-5. PubMed ID: 17319724
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, labeling, and biological evaluation of halogenated 2-quinolinecarboxamides as potential radioligands for the visualization of peripheral benzodiazepine receptors.
Cappelli A; Matarrese M; Moresco RM; Valenti S; Anzini M; Vomero S; Turolla EA; Belloli S; Simonelli P; Filannino MA; Lecchi M; Fazio F
Bioorg Med Chem; 2006 Jun; 14(12):4055-66. PubMed ID: 16495062
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of 2-(4-biphenylyl)quinoline-4-carboxylate and carboxamide analogs. New human neurokinin-3 (hNK-3) receptor antagonists.
Saudi MN; Rostom SA; Fahmy HT; El Ashmawy IM
Arch Pharm (Weinheim); 2003 Jun; 336(3):165-74. PubMed ID: 12822182
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and first in vivo evaluation of new selective high affinity beta1-adrenoceptor radioligands for SPECT based on ICI 89,406.
Wagner S; Kopka K; Law MP; Riemann B; Pike VW; Schober O; Schäfers M
Bioorg Med Chem; 2004 Aug; 12(15):4117-32. PubMed ID: 15246089
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of new 4-heteroaryl-2-phenylquinolines and their pharmacological activity as NK-2/NK-3 receptor ligands.
Borioni A; Mustazza C; Sestili I; Sbraccia M; Turchetto L; Del Giudice MR
Arch Pharm (Weinheim); 2007 Jan; 340(1):17-25. PubMed ID: 17206605
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of 18F-labeled dopamine D3 receptor ligands as potential PET imaging agents.
Hocke C; Prante O; Löber S; Hübner H; Gmeiner P; Kuwert T
Bioorg Med Chem Lett; 2005 Nov; 15(21):4819-23. PubMed ID: 16139501
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and receptor binding studies of halogenated N,N-dialkylel-(2-phenyl-1H-indol-3-yl)glyoxylamides to visualize peripheral benzodiazepine receptors with SPECT or PET.
Bennacef I; Haile CN; Schmidt A; Koren AO; Seibyl JP; Staley JK; Bois F; Baldwin RM; Tamagnan G
Bioorg Med Chem; 2006 Nov; 14(22):7582-91. PubMed ID: 16908169
[TBL] [Abstract][Full Text] [Related]
11. Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.
Huang Y; Bae SA; Zhu Z; Guo N; Roth BL; Laruelle M
J Med Chem; 2005 Apr; 48(7):2559-70. PubMed ID: 15801845
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological characterization of novel 2-quinolinecarboxamide ligands of the peripheral benzodiazepine receptors bearing technetium-99m or rhenium.
Cappelli A; Mancini A; Sudati F; Valenti S; Anzini M; Belloli S; Moresco RM; Matarrese M; Vaghi M; Fabro A; Fazio F; Vomero S
Bioconjug Chem; 2008 Jun; 19(6):1143-53. PubMed ID: 18510350
[TBL] [Abstract][Full Text] [Related]
13. Senktide-induced gerbil foot tapping behaviour is blocked by selective tachykinin NK1 and NK3 receptor antagonists.
Sundqvist M; Kristensson E; Adolfsson R; Leffler A; Ahlstedt I; Engberg S; Drmota T; Sigfridsson K; Jussila R; de Verdier J; Novén A; Johansson A; Påhlman I; von Mentzer B; Lindström E
Eur J Pharmacol; 2007 Dec; 577(1-3):78-86. PubMed ID: 17920583
[TBL] [Abstract][Full Text] [Related]
14. New quinoline NK3 receptor antagonists with CNS activity.
Smith PW; Wyman PA; Lovell P; Goodacre C; Serafinowska HT; Vong A; Harrington F; Flynn S; Bradley DM; Porter R; Coggon S; Murkitt G; Searle K; Thomas DR; Watson JM; Martin W; Wu Z; Dawson LA
Bioorg Med Chem Lett; 2009 Feb; 19(3):837-40. PubMed ID: 19117759
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, structural studies, biological evaluation, and computational simulations of novel potent AT(1) angiotensin II receptor antagonists based on the 4-phenylquinoline structure.
Cappelli A; Pericot Mohr Gl Gl; Gallelli A; Rizzo M; Anzini M; Vomero S; Mennuni L; Ferrari F; Makovec F; Menziani MC; De Benedetti PG; Giorgi G
J Med Chem; 2004 May; 47(10):2574-86. PubMed ID: 15115399
[TBL] [Abstract][Full Text] [Related]
16. Ring-fluorinated isoquinoline and quinoline synthesis: intramolecular cyclization of o-cyano- and o-isocyano-beta,beta-difluorostyrenes.
Ichikawa J; Wada Y; Miyazaki H; Mori T; Kuroki H
Org Lett; 2003 May; 5(9):1455-8. PubMed ID: 12713297
[TBL] [Abstract][Full Text] [Related]
17. [Strategy for development of imaging biomarkers].
Ishiwata K
Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Apr; 29(2):67-71. PubMed ID: 19562944
[TBL] [Abstract][Full Text] [Related]
18. 5-substituted derivatives of 6-halogeno-3-((2-(S)-azetidinyl)methoxy)pyridine and 6-halogeno-3-((2-(S)-pyrrolidinyl)methoxy)pyridine with low picomolar affinity for alpha4beta2 nicotinic acetylcholine receptor and wide range of lipophilicity: potential probes for imaging with positron emission tomography.
Zhang Y; Pavlova OA; Chefer SI; Hall AW; Kurian V; Brown LL; Kimes AS; Mukhin AG; Horti AG
J Med Chem; 2004 May; 47(10):2453-65. PubMed ID: 15115389
[TBL] [Abstract][Full Text] [Related]
19. Replacement of the quinoline system in 2-phenyl-4-quinolinecarboxamide NK-3 receptor antagonists.
Giardina GA; Artico M; Cavagnera S; Cerri A; Consolandi E; Gagliardi S; Graziani D; Grugni M; Hay DW; Luttmann MA; Mena R; Raveglia LF; Rigolio R; Sarau HM; Schmidt DB; Zanoni G; Farina C
Farmaco; 1999 Jun; 54(6):364-74. PubMed ID: 10443017
[TBL] [Abstract][Full Text] [Related]
20. A1 adenosine receptor antagonists as ligands for positron emission tomography (PET) and single-photon emission tomography (SPET).
Holschbach MH; Fein T; Krummeich C; Lewis RG; Wutz W; Schwabe U; Unterlugauer D; Olsson RA
J Med Chem; 1998 Feb; 41(4):555-63. PubMed ID: 9484505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
